Singapore: Amendment to the Patent Declarations Regulations
brief The Health Products (Therapeutic Products) Regulations (“Regulation”) was recently amended through the Health Products (Therapeutic Products) (Amendment) Regulations 2024. The amendments came into effect on August 1, 2024. These changes are intended to provide clarity to stakeholders about which patents need to be considered when applying to register a therapeutic product and which patents fall under the patent claims regulations. In addition, they seek to reduce the potential for abuse of the patent claims process. The revised patent declaration requirements are intended to reduce the number ofHuman serum albuminTo achieve this, the HSA will notify patent owners of the registration of products covered by them during the patent's validity period without requiring their consent or approval. In particular, it is now clear that process patents do not fall within the scope of Article 23 of the Regulation. Any person who makes a false patent claim in an application for registration of a therapeutic product, such as: (a) making any…
Explore the latest exhibition information and industry trends at ASAP Expo Magazine. Your one-stop platform, bringing together global exhibition highlights, industry trends and in-depth analysis, to help companies accurately connect with the market and seize business opportunities.
